Short-term treatment of multidrug-resistant tuberculosis: a multicenter study of therapeutic effectiveness and adverse drug reactions in Yogyakarta, Indonesia

印度尼西亚日惹市一项多中心研究:多重耐药结核病短期治疗的疗效和不良反应

阅读:1

Abstract

This study analyzed the therapeutic effectiveness, ADRs, and their influencing factors in multidrug-resistant tuberculosis (MDR-TB) patients. We conducted a cross-sectional study involving patients in four referral hospitals in Yogyakarta province. The data was collected from the medical records and the Tuberculosis Information System (SITB) of the Ministry of Health of the Republic of Indonesia from January 2020 to June 2023. Of the 65 patients, 31 (47.7%) showed the expected clinical response. The factors affecting the therapeutic effectiveness were occupation and medication adherence. The most frequent ADR found was gastrointestinal disorders (19.9%). Based on the severity levels, the most frequently found ADRs were levels 1 and 3, at 60.1% and 26.1%, respectively. In conclusion, more than half of all the MDR-TB patients still showed an inadequate clinical response, with almost 40% of MDR-TB patients experiencing ADRs.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。